For Healthcare Professionals
As a professional, Eisai aims to support you in the treatment of your patients. In this section you will find information, including: Summary of Product Characteristics (SPC) and Product Information Leaflets (PIL).
If you require further information regarding one of our products, please use the Medical Information Enquiry Form.
Please follow the links to find further details of the medicines available in the UK.
Reporting Adverse Events
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard
Adverse events should also be reported to Eisai Ltd on one of the options below:
+44 (0)208 600 1400
EUmedinfo@eisai.net

Oncology
-
Halaven®
eribulin mesylate Summary of Product Characteristics Great BritainSummary of Product Characteristics Northern Ireland Patient Information Leaflet Great BritainPatient Information Leaflet Northern Ireland -
Kisplyx®
lenvatinib Summary of Product Characteristics Great BritainSummary of Product Characteristics Northern Ireland Patient Information Leaflet Great BritainPatient Information Leaflet Northern Ireland -
Lenvima®
lenvatinib Summary of Product Characteristics Great BritainSummary of Product Characteristics Northern Ireland Patient Information Leaflet Great BritainPatient Information Leaflet Northern Ireland -
Gliadel®
carmustine Summary of Product Characteristics Patient Information Leaflet -
Targretin®
bexarotene Summary of Product Characteristics Great BritainSummary of Product Characteristics Northern Ireland Patient Information Leaflet Great BritainPatient Information Leaflet Northern Ireland
Neurology
-
Fycompa®
perampanel Tablets Great BritainSuspension Great BritainTablets Northern IrelandSuspension Northern Ireland Tablets Great BritainSuspension Great BritainTablets Northern IrelandSuspension Northern Ireland -
Inovelon®
rufinamide Tablets Great BritainSuspension Great BritainTablets Northern IrelandSuspension Northern Ireland Tablets Great BritainSuspension Great BritainTablets Northern IrelandSuspension Northern Ireland -
Aricept®
donepezil hydrochloride Summary of Product Characteristics Patient Information Leaflet -
Aricept Evess®
donepezil hydrochloride Summary of Product Characteristics Patient Information Leaflet -
Zonegran®
zonisamide Summary of Product Characteristics Great BritainSummary of Product Characteristics Northern Ireland Patient Information Leaflet Great BritainPatient Information Leaflet Northern Ireland
Others
-
Pariet®
rabeprazole Summary of Product Characteristics Patient Information Leaflet